News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Deals
AutoGenomics Pulls $60 Million IPO
February 19, 2013
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
AutoGenomics, which provides a molecular diagnostics system for genetic testing in clinical laboratories, withdrew its IPO on Friday, according to an underwriter.
Twitter
LinkedIn
Facebook
Email
Print
IPO
MORE ON THIS TOPIC
IPO
Swiss ADC Biotech Takes SPAC Track to NASDAQ
April 23, 2025
·
1 min read
·
Annalee Armstrong
Deals
Genentech Offers up to $765M in Biobucks to Repertoire for I&I Drug Discovery
April 23, 2025
·
1 min read
·
Dan Samorodnitsky
Deals
Unusual New Fund Launches to Unlock Some $30B of Capital ‘Trapped’ in Public Biotechs
April 18, 2025
·
3 min read
·
Annalee Armstrong
Mergers & acquisitions
Bluebird’s Second Suitor, Ayrmid, Fails To Produce an Offer
April 16, 2025
·
1 min read
·
Dan Samorodnitsky
